Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Gıancarlo Comı(Casa di Cura Columbus), Massimo Filippi(Vita-Salute San Raffaele University), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Alexey Boyко(Pirogov Russian National Research Medical University), Ludwig Kappos(University Hospital of Basel), Maria A. Rocca(Vita-Salute San Raffaele University), Douglas Jeffery(University of New Mexico)
Cited by 362
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k